share_log

Citius Pharmaceuticals将于2024年11月26日除权除息,25股合为1股

Citius Pharmaceuticals To Carry Out 1-for-25 Reverse Stock Split On November 26th, 2024

Futu News ·  Nov 23 08:40

November 22nd (Eastern Time) - $Citius Pharmaceuticals (CTXR.US)$ is about to implement a 1-for-25 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from November 26th, 2024.

$Citius Pharmaceuticals (CTXR.US)$ slipped 2.83% and closed at $0.1651 on November 21st with a turnover of $777.99K. $Citius Pharmaceuticals (CTXR.US)$ now has a total market capitalization of $31.89 million.


What Is a Reverse Stock Split?

A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.

Note:

The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment